Hunan Jiudian Pharmaceutical Co Ltd (300705) — Cash Flow-to-Debt Ratio
Hunan Jiudian Pharmaceutical Co Ltd (300705) has a Cash Flow-to-Debt Ratio of 0.18x as of September 2025, meaning its operating cash flow of CN¥180.33 Million could theoretically repay 0% of its total liabilities (CN¥1.02 Billion) in one year. See 300705 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hunan Jiudian Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Hunan Jiudian Pharmaceutical Co Ltd across 13 annual periods. For the full cash flow conversion analysis, see 300705 cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Hunan Jiudian Pharmaceutical Co Ltd (2013–2025)
Year-by-year debt coverage analysis for Hunan Jiudian Pharmaceutical Co Ltd. Check Hunan Jiudian Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.52x | CN¥647.06 Million | CN¥1.23 Billion | ▼ -40.5% |
| 2024 | 0.88x | CN¥746.36 Million | CN¥846.40 Million | ▲ +83.6% |
| 2023 | 0.48x | CN¥431.19 Million | CN¥897.93 Million | ▲ +33.4% |
| 2022 | 0.36x | CN¥268.99 Million | CN¥747.05 Million | ▲ +21.8% |
| 2021 | 0.30x | CN¥190.87 Million | CN¥645.90 Million | ▼ -41.9% |
| 2020 | 0.51x | CN¥149.99 Million | CN¥295.04 Million | ▲ +73.8% |
| 2019 | 0.29x | CN¥90.74 Million | CN¥310.23 Million | ▼ -3.5% |
| 2018 | 0.30x | CN¥68.23 Million | CN¥225.05 Million | ▼ -58.9% |
| 2017 | 0.74x | CN¥80.42 Million | CN¥108.95 Million | ▼ -1.5% |
| 2016 | 0.75x | CN¥55.18 Million | CN¥73.60 Million | ▲ +48.6% |
| 2015 | 0.50x | CN¥32.20 Million | CN¥63.81 Million | ▼ -1.6% |
| 2014 | 0.51x | CN¥30.11 Million | CN¥58.71 Million | ▲ +27.5% |
| 2013 | 0.40x | CN¥30.69 Million | CN¥76.30 Million | — |